11th Liquid Biopsy for Precision Oncology Summit West Coast
With IMvigor011 and SERENA-6 reinventing how biopharma conduct clinical trials, and increasingly, sensitive, specific tests transforming the very foundations of drug development, liquid biopsy has rapidly emerged from an innovative to necessary tool.
As the only dedicated forum convening the global liquid biopsy community, the 11th Liquid Biopsy for Precision Oncology Summit West Coast offers a look at how this novel technology is delivering value at every stage of the clinical development lifecycle.
Across 3 days, deep dive into the applications that matter most to your team's trial with dedicated sessions spanning dose optimization and therapeutic monitoring through to patient selection and diagnostics.
Get your hands on the 2027 agenda.
Our KOL speakers will provide insights on:
- Utilizing ctDNA dynamics to measure the optimal dose faster to ensure you meet FDA Project Optimus expectations, without adding months to your timeline
- Improving patient selection and resistance monitoring by identifying loss of target expression across successive lines of therapy in ADCs, T-cell engagers, radioligand therapies and more
- How to choose the right assay partner by offering the specific questions you should be asking, which is especially important at a time when the vendor landscape is consolidating fast
Seize the opportunity to join 250+ liquid biopsy professionals in the conversations, shared experiences and new collaborations that will dictate the future of global liquid biopsy adoption.
Registration is available here.
Attendance is free* for eligible biopharma and researchers. Head to our website to check your eligibility and reserve your pass.
Early registration discounts are also available on vendor and solution provider tickets. Claim yours early for the chance to join us at the best rate.
